menu 1
menu 2
menu 3
menu 4
menu 5
menu 6
menu 7

The AdnaTest ColonCancer and AdnaTest BreastCancer products are CE-certified for the detection of circulating tumor cells.

The following in-vitro diagnostic test systems for the selection and detection of breast and colon cancer cells in human blood can be ordered from Innogenetics.

Important note for US customers: In USA, AdnaTest BreastCancer and AdnaTest ColonCancer are not yet approved by the FDA and must not be used for diagnostic purposes; these kits are for research use only. AdnaGen disclaims all liabilities for any diagnostic application.
Name
Size
Art. No.
  
Manual
AdnaTest ColonCancerSelect
12 selections
T-1-504
  
24 selections
T-1-512
  
36 selections
T-1-514
  
AdnaTest ColonCancerDetect
12 detections
T-1-505
  
24 detections
T-1-513
  
36 detections
T-1-515
  
AdnaTest BreastCancerSelect
12 selections
T-1-508
  
24 selections
T-1-516
  
36 selections
T-1-518
  
AdnaTest BreastCancerDetect
12 detections
T-1-509
  
24 detections
T-1-517
  
36 detections
T-1-519
  
AdnaCollect
12 systems
T-1-600
    

 

Product description
AdnaTest CancerSelect
In the first step cancer cells will be enriched in vitro from cancer patients` blood samples (EDTA or AdnaCollect) using magnetic bead conjugated antibodies. The antibody cocktail was carefully optimized for the cancer type.

AdnaTest CancerDetect
The isolated mRNA is transcribed into cDNA, that can be amplified in a following multiplex-PCR. The multiplex PCR detection step analyses the tumor associated gene expression of a variety of relevant tumor markers to make sure that the selected cells are cancer cells. Tests are offered as reagent sets for the detection of breast and colon cancer cells in human blood.

The advantages of AdnaGen's test
The combination of a variety of selection markers (antibodies) and a set of molecular tumor markers (mRNAs) takes care of the heterogeneity of the cancer cells` gene expression preventing false negative and false positive results due to either illegitimate transcription in normal cells or individual changes in gene expression in general and during chemotherapy.